Monday, October 6, 2025
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Breaking News

Analyst Karl Keirstead Bullish on GitLab with Buy Rating and Revised Price Target

Elaine Mendonca by Elaine Mendonca
March 5, 2024
in Breaking News
0
Biotechnology Stock Bull Market
0
SHARES
0
VIEWS
Share on FacebookShare on Twitter

Analyst Karl Keirstead from UBS reiterates his bullish stance on GitLab (NASDAQ: GTLB) with a Buy rating, while revising the price target down to $75 from $81. Keirstead remains optimistic about the company’s future prospects and believes in its potential for growth.

GTLB Stock Plummets by 18.67% on March 5, 2024: What Investors Need to Know

On March 5, 2024, GTLB stock experienced a significant drop in price, with shares decreasing by $13.90 since the previous market close. This represents an 18.67% decrease in value, which is a significant decline for investors holding GTLB shares.

The stock opened at $59.95 on March 5, which was $14.52 lower than its previous close. This sharp drop in the opening price indicates that there was likely negative sentiment surrounding GTLB on that day, leading to a sell-off by investors.

Despite this drop in price, GTLB is still trading in the middle of its 52-week range and above its 200-day simple moving average. This suggests that while there was a significant decline on March 5, the stock’s overall performance has been relatively stable compared to its historical range.

GTLB Stock Analysis: Mixed Performances in Revenue, Net Income, and EPS

On March 5, 2024, GTLB stock experienced mixed performances based on the financial data provided by CNN Money. The company reported a total revenue of $579.91 million for the past year, representing a 36.66% increase compared to the previous year. Additionally, the total revenue for the fourth quarter was $163.78 million, showing a 9.43% increase from the previous quarter.

GTLB reported a net income of -$424.17 million for the past year, which is a significant decrease of 146.17% compared to the previous year. On a positive note, the net income for the fourth quarter improved to -$36.47 million, representing an 87.21% increase from the previous quarter.

Earnings per share (EPS) also showed a mixed performance for GTLB stock. The EPS for the past year was -$2.75, indicating a 136.78% decrease compared to the previous year. Interestingly, the EPS for the fourth quarter remained unchanged at -$0.23 compared to the previous quarter.

Overall, the financial data suggests that GTLB stock has experienced both positive and negative performances in various aspects of its financials. Investors may want to closely monitor the company’s future earnings reports and financial updates to assess the stock’s performance and make informed investment decisions.

Tags: GTLB
Elaine Mendonca

Elaine Mendonca

Related Posts

NFT projects
Breaking News

The Impact of TikToks Fate on USChina Relations and American Tech Giants

March 16, 2024
Businesses finance
Breaking News

Blackstone Strategic Credit 2027 Term Fund BGB Announces Monthly Dividend of 93 Cents per Share

March 15, 2024
Healthcare-sector
Breaking News

Analyzing Short Interest in Molina Healthcare Inc MOH

March 15, 2024
Next Post
Finance_ stocks to buy

UBS Analyst Maintains Neutral Rating on Ziff Davis Lowers Price Target to 76

Finance_ projections

Jonathan Painter Sells 23 Million Worth of Kadant Stock

Finance_Assets (2)

SunOpta Receives Buy Rating and Increased Price Target from Analysts

Recommended

Sabre Stock

Sabre Shares Face Unrelenting Pressure: Can the Travel Tech Giant Recover?

4 weeks ago
High-tech-digital-medicine

Unlocking Market Potential: Leveraging Big Data Analytics to Revolutionize Depression Research

2 years ago
Biotechnology Trading online

Heartbeam Inc BEAT Stock Rises on New Patents and Analyst Optimism

2 years ago
Palantir Stock

Security Flaws in Military System Trigger Palantir Stock Plunge

1 day ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple BigBear.ai BioNTech Broadcom Coinbase Eli Lilly Fiserv Hims & Hers IBM Intel Kraft Heinz Lockheed Marvell Technology META Micron Microsoft MP Materials MSCI World ETF NIO Nvidia Ocugen Opendoor Oracle Oxford Lane Capital Palantir PayPal Plug Power Realty Income Red Cat Robinhood Rocket Lab USA Salesforce Strategy Super Micro Computer Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics Wolfspeed
No Result
View All Result

Highlights

The Trade Desk’s AI Innovation Sparks Market Optimism

Tech-Led Rally Stalls as Nasdaq 100 Retreats From Record High

Chip Industry Upheaval: AMD and Intel Explore Unprecedented Partnership

Coinbase Shares Defy Legal Challenges with Strong Market Performance

BioNTech Stock Surges on AI Breakthroughs and Cancer Research Milestones

Quantum Computing Stock Soars on Breakthrough Police Deployment

Trending

Viking Therapeutics Stock
Mergers & Acquisitions

Acquisition Speculation Fuels Viking Therapeutics Stock Surge

by Felix Baarz
October 6, 2025
0

Viking Therapeutics shares experienced a significant rally over the weekend, propelled by mounting speculation about a potential...

Lockheed Martin Stock

Defense Giant Lockheed Martin Secures Billions in New Military Contracts

October 6, 2025
Kadant Stock

Kadant’s Financial Strategy Faces Market Headwinds

October 6, 2025
Trade Desk Stock

The Trade Desk’s AI Innovation Sparks Market Optimism

October 6, 2025
NASDAQ 100 Stock

Tech-Led Rally Stalls as Nasdaq 100 Retreats From Record High

October 5, 2025

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • Acquisition Speculation Fuels Viking Therapeutics Stock Surge
  • Defense Giant Lockheed Martin Secures Billions in New Military Contracts
  • Kadant’s Financial Strategy Faces Market Headwinds

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com